BiotechTube
Home/Xilio Therapeutics/Chris Frankenfield
CF

Chris Frankenfield

Chief Financial and Operating Officer

Xilio Therapeutics

Therapeutic Areas

Oncology

Xilio Therapeutics Pipeline

DrugIndicationPhase
XTX101Advanced solid tumorsPhase 1
XTX202Advanced solid tumorsPhase 1

Leadership Team at Xilio Therapeutics

RR
René Russo
President, Chief Executive Officer and Board Member
UB
Uli Bialucha
Chief Scientific Officer
SC
Scott Coleman
Chief Development Officer
View full Xilio Therapeutics profile